Provider preferences for DVT prophylaxis

Thrombosis Research

Volumn 117, Issue 5, 2006, Pages 563-568

  Holley, Aaron B ^a,c   Moores, Lisa K ^b   Jackson, Jeffrey L ^b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; DEEP VEIN THROMBOSIS; EVALUATION; HEALTH CARE PERSONNEL; HEALTH SURVEY; HUMAN; MEDICAL SPECIALIST; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TERTIARY HEALTH CARE; THROMBOSIS PREVENTION;

ADOLESCENT; AGED; ANTICOAGULANTS; CLINICAL COMPETENCE; FEMALE; HEALTH CARE SURVEYS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEPARIN; HUMANS; INPATIENTS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; VENOUS THROMBOSIS;

EID: 33644643487     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2005.04.010     Document Type: Article

References (24)

1. J.F. Bergman, and D. Elkharrat Prevention of venous thromboembolic risk in non-surgical patients Haemostasis 26 Suppl. 2 1996 16 23
2. P. Mismetti, S. Laporte-Simitsidis, B. Tardy, M. Cucherat, A. Buchmuller, and D. Juillard-Delsart Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials Thromb Haemost 83 2000 14 19
3. W.H. Geerts, G.F. Pineo, J.A. Heit, D. Bergquist, M.R. Lassen, and C.W. Colwell Prevention of venous thromboembolism Chest 126 2004 338S 400S
4. M. O'Flaherty, K. Lerum, P. Martin, and D. Grassi Low agreement for assessing the risk of postoperative deep venous thrombosis when deciding prophylaxis strategies: a study using clinical vignettes BMC Health Serv Res 2002 1 3
5. J.I. Arcelus, S. Candocia, C.I. Traverso, F. Faberga, J.A. Caprini, and J.H. Hasty Venous thromboembolism prophylaxis and risk assessment in medical patients Semin Thromb Hemost 17 3 1991 313 318
6. S.Z. Goldhaber, K. Dunn, and R.C. MacDougall New onset of venous thromboembolism among hospitalized patients at Brigham and Women's Hospital is caused more often by prophylaxis failure than by withholding treatment Chest 118 2000 1680 1684
7. Thromboembolic Risk Factors (THRIFT) Consensus Group: risk of and prophylaxis for venous thromboembolism in hospital patients Br Med J 305 1992 567 574
8. J. Harenberg, U. Schomaker, and C.W. Flosbach Enoxaparin is superior to unfractionated heparin in the prevention of thromboembolic events in medical patients at increased thromboembolic risk Blood 2000 399a
9. J.J. Belch, G.D.O. Lowe, A.G. Ward, C.D. Forbes, and C.R. Prentice Prevention of deep vein thrombosis in medical patients by low dose heparin Scott Med J 26 1981 115 117
10. J.F. Cade High risk of the critically ill for VTE Crit Care Med 10 1982 448 450
11. M.M. Samana, A.T. Cohen, J.Y. Darmon, L. Deslardins, A. Eldor, C. Janbon for the Prophylaxis in Medical Patients with Enoxaparin Study Group A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients (MEDENOX) N Engl J Med 341 11 1999 793 800
12. R. Danan, D. Holbert, C. Caulin, E. Cuzin, C. Viltart, and M. Woler Prevention of deep vein thrombosis in elderly medical patients by a low molecular weight heparin: a randomized double-blind trial Haemostasis 16 1986 159 164
13. F.X. Kleber, C. Witt, G. Vogel, K. Koppenhagen, U. Schomaker, C.W. Flosbach for THE-PRINCE Study Group Berlin, Erfurt, and Cologne, Germany Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease Am Heart J 145 2003 614 621
14. E. Lechler, W. Schramm, and C.W. Flosbach The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy/safety profile of a low-molecular-weight heparin (enoxaparin). The PRIME Study Haemostasis 26 Suppl. 2 1996 49 56
15. E.H. Ibrahim, M. Irequi, D. Prentice, G. Sherman, and M. Kollef Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis Crit Care Med 30 4 2002 771 774
16. J. Harenberg Risk assessment of venous thromboembolism in medical patients Semin Hematol 37 Suppl. 5 2000 3 6
17. D.R. Hirsch, E.P. Ingenito, and SZ. Goldhaber Prevalence of deep venous thrombosis among patients in medical intensive care JAMA 274 4 1995 335 337
18. E. Oger, L. Bressollette, M. Nonent, K. Lacut, B. Guias, and F. Couturaud High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients: the TADEUS Project Thromb Haemost 88 2002 592 597
19. J.A. Heit, W.M. O'Fallon, T.M. Petterson, C.M. Lohse, M.D. Silverstein, and D.N. Mohr Relative impact of risk factors for deep venous thrombosis and pulmonary embolism Arch Intern Med 162 2002 1245 1248
20. J.A. Heit, M.D. Silverstein, D.N. Mohr, T.M. Petterson, W.M. O'Fallon, and L.G. Melton III Risk factors for deep venous thrombosis and pulmonary embolism Arch Intern Med 160 2000 809 815
21. M.N. Levine, M. Gent, J. Hirsch, A. Arnold, M.D. Goodyear, and W. Hryniuk The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer N Engl J Med 318 1988 404 407
22. M.M. Samama An epidemiologic study of risk factors for deep venous thrombosis in medical outpatients. The Sirius Study Arch Intern Med 160 2000 3415 3420
23. A.N. Nicolaides, D. Bergqvist, R. Hull, R.S. Ackchurin, C. Allegra, and J. Arcelus Prevention of venous thromboembolism Int Angiol 16 1 1997 3 38
24. J.A. Ambrose, and R.S. Barua The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol 43 10 2004 1731 1737